Revolution Medicines Inc
NASDAQ:RVMD
Revolution Medicines Inc
NASDAQ:RVMD
Price:
39.39 USD
5.38%
Updated:
May 16, 2024
Balance Sheet
Balance Sheet Decomposition
Revolution Medicines Inc
Revolution Medicines Inc
| Current Assets | 1.7B |
| Cash & Short-Term Investments | 1.7B |
| Other Current Assets | 25.7m |
| Non-Current Assets | 179.2m |
| PP&E | 99.9m |
| Intangibles | 72.1m |
| Other Non-Current Assets | 7.2m |
| Current Liabilities | 93.7m |
| Accounts Payable | 32.4m |
| Accrued Liabilities | 60.6m |
| Other Current Liabilities | 744k |
| Non-Current Liabilities | 89.2m |
| Other Non-Current Liabilities | 89.2m |
Balance Sheet
Revolution Medicines Inc
Revolution Medicines Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
9
|
70
|
17
|
104
|
109
|
161
|
696
|
|
| Cash Equivalents |
9
|
70
|
17
|
104
|
109
|
161
|
696
|
|
| Short-Term Investments |
0
|
0
|
106
|
337
|
469
|
484
|
1 157
|
|
| Total Receivables |
0
|
7
|
9
|
6
|
6
|
5
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
6
|
5
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
9
|
3
|
7
|
7
|
11
|
25
|
|
| Total Current Assets |
9
|
85
|
134
|
454
|
590
|
660
|
1 879
|
|
| PP&E Net |
5
|
7
|
7
|
36
|
71
|
74
|
100
|
|
| PP&E Gross |
5
|
7
|
7
|
36
|
71
|
74
|
100
|
|
| Accumulated Depreciation |
2
|
4
|
6
|
8
|
11
|
15
|
18
|
|
| Intangible Assets |
0
|
63
|
62
|
61
|
60
|
59
|
58
|
|
| Goodwill |
0
|
15
|
15
|
15
|
15
|
15
|
15
|
|
| Other Long-Term Assets |
0
|
1
|
3
|
1
|
3
|
5
|
10
|
|
| Other Assets |
0
|
15
|
15
|
15
|
15
|
15
|
15
|
|
| Total Assets |
15
N/A
|
171
+1 030%
|
221
+29%
|
567
+157%
|
738
+30%
|
812
+10%
|
2 062
+154%
|
|
| Liabilities | ||||||||
| Accounts Payable |
3
|
5
|
11
|
13
|
14
|
21
|
62
|
|
| Accrued Liabilities |
3
|
7
|
13
|
22
|
34
|
36
|
78
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
18
|
19
|
12
|
13
|
5
|
4
|
|
| Total Current Liabilities |
8
|
31
|
43
|
47
|
60
|
62
|
144
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
12
|
8
|
7
|
7
|
7
|
3
|
|
| Other Liabilities |
3
|
31
|
17
|
38
|
68
|
58
|
89
|
|
| Total Liabilities |
11
N/A
|
74
+604%
|
68
-8%
|
93
+36%
|
135
+46%
|
127
-6%
|
236
+86%
|
|
| Equity | ||||||||
| Common Stock |
72
|
205
|
305
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
68
|
110
|
157
|
266
|
453
|
701
|
1 138
|
|
| Additional Paid In Capital |
0
|
1
|
5
|
740
|
1 056
|
1 388
|
2 963
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
|
| Total Equity |
5
N/A
|
97
+2 049%
|
153
+58%
|
475
+211%
|
603
+27%
|
685
+14%
|
1 826
+167%
|
|
| Total Liabilities & Equity |
15
N/A
|
171
+1 030%
|
221
+29%
|
567
+157%
|
738
+30%
|
812
+10%
|
2 062
+154%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
53
|
53
|
59
|
67
|
74
|
91
|
165
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
